NetworkNewsBreaks

MondayApr 11, 2022 2:23 pm

NetworkNewsBreaks – CE Brands Inc. (TSX.V: CEBI) Announces Preliminary Q4 2022 Results Reflecting Improving Sales, Portfolio’s Revenue Potential

CE Brands (TSX.V: CEBI), a data-driven consumer-electronics company, has announced selected preliminary unaudited financial and operational results for the fourth quarter ended March 31, 2022 (“Q4 2022”). According to the update, CE Brands issued today’s press release pursuant to its obligations under applicable Canadian securities laws to enable it to disclose the information in meetings with prospective investors as it explores a range of near-term financing opportunities. “Our preliminary Q4 2022 revenue results reflect improving sales trends and the revenue generating potential of our expanding portfolio of branded products. We introduced two new products to the market in the past…

Continue Reading

MondayApr 11, 2022 1:53 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Better Equips Itself for Long-Term Growth Plans

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, has promoted four employees to executive positions. Doris Lam has been named vice president of finance, Jason M Gonzalez has been named senior vice president of client development, Ronald J Gallegos has been named vice president of client experience and Ryan J Fanciullo has been named vice president of operations. According to the announcement, these employees  have demonstrated exceptional leadership abilities and have been promoted to capitalize on Knightscope’s current momentum as the company continues focusing on product innovation and sales growth. The new…

Continue Reading

MondayApr 11, 2022 1:47 pm

NetworkNewsBreaks – Lift&Co. Expo to Showcase Top-Tier Speakers, Products, Services and Cannabis Industry Innovations

Lift&Co. Expo, Canada's no. 1 cannabis conference and trade show, will be held at the Metro Toronto Convention Centre next month. The event, slated to take place May 12-15, 2022, will feature top-tier speakers, hundreds of leading exhibitors, giveaways, 420 receptions, live entertainment and more. This year’s expo is expected to bring together more than 10,000 attendees and over 250 exhibitors showcasing hundreds of products, services and cannabis industry innovations. The event will kick off with the Lift Cannabis Business Conference (“LCBC”) on May 12, the premier gathering of Canada's top business leaders, subject matter experts, innovators and regulators across…

Continue Reading

MondayApr 11, 2022 1:36 pm

NetworkNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Completes Name and Ticker Symbol Change

Correlate Infrastructure Partners (OTCQB: CIPI) today announced completion of the company’s corporate name change from Triccar Inc. to Correlate Infrastructure Partners Inc. In conjunction with the name change, the company’s ticker symbol changed to CIPI, effective at the open of market trading on April 11, 2022. “This name change accurately reflects Correlate's Net Zero solution scope for property owners while making it clear we are an open ecosystem supporting industry partners across North America,” said Correlate Infrastructure Partners CEO Todd Michaels. “Since the merger of two operating companies, Correlate Inc. and Loyal Enterprises LLC (dba Solar Site Design) in December…

Continue Reading

MondayApr 11, 2022 1:24 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Beginning of New Nicotine Formulation Creation, Evaluation Program

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has entered agreements with Altria Client Services LLC. According to the announcement, the agreements call for Lexaria to provide specific DehydraTECH(TM) powder-based nicotine formulations for a fee; Altria in turn will evaluate the formulations. The new agreements will continue through March 31, 2023. Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. In addition, the technology has shown the ability to increase bioabsorption with cannabinoids and nicotine by up to 10 times as well as decrease time…

Continue Reading

MondayApr 11, 2022 12:37 pm

NetworkNewsBreaks – Friendable Inc. (FDBL) Releases New Corporate Presentation, Announces Steady Growth in Key Categories

Friendable (OTC: FDBL) today released a new corporate presentation and 2022 strategy and announced additional increases in certain key metrics driving the company’s growth, as its 360 offering sees increased traction, revenue and user retention. As the Fan Pass Live platform has expanded, the company’s other brands associated with its 360 offering have exceeded expectations, with the Artist Republik and FeaturedX products and services continuing to produce positive results. “Hearing from our artists, their experiences, as well as simply listening to how our offering can better support their journey to success has been one of the most rewarding parts of…

Continue Reading

MondayApr 11, 2022 11:42 am

NetworkNewsBreaks – GreenBox POS (NASDAQ: GBOX) Names Seasoned Transactional Attorney to Board of Directors

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has named a new member of its board of directors. The company has appointed transactional lawyer Adele Hogan to the board; Hogan will replace Carl Williams. With more than three decades of experience, Hogan has been involved in an estimated $200 billion of securities, mergers, contracts and closed deals. She is currently a partner at Lucosky Brookman, where she also serves as the cochair of the Corporate, Mergers & Securities Practice Group overseeing mergers and capital markets transactions including IPOs, SPACs, de-SPACs, corporate side of bankruptcies, securities and derivatives. Previously…

Continue Reading

FridayApr 08, 2022 3:32 pm

NetworkNewsBreaks – Hero Technologies Inc. (HENC) Focusing on Expansion of Current Operations, Future Industry Growth

Hero Technologies (OTC: HENC) has made key acquisitions and investments that have played an essential role in its strategic business plan and operations. During a recent episode of the Bell2Bell Podcast hosted by Stuart Smith, company CEO Gina Serkasevich discussed HENC’s careful expansion moves. “In 2020, ‘both Highly Relaxing and the assets of V Brokers, under Veteran Hemp Co., were acquired,’ said Serkasevich. ‘Both of these entities gave Hero a foot in the door to establish itself as a cannabis player. Since then, our biggest advancement was becoming a majority stakeholder in BlackBox Systems and Technologies,’” a recent article reads.…

Continue Reading

FridayApr 08, 2022 2:51 pm

NetworkNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Eyeing Additional Investments to Expand Portfolio Companies’ Reach

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF), a growing company strengthening its end-to-end supply chain production of nutritious foods through strategic acquisitions, is working to overcome global forces such as the war in Ukraine in its efforts to transform entire industries such as meat and dairy with nutrition-focused operations. “The world is witnessing one of the worst global supply chains in history. Getting products in containers on planes, trains and ships to meet the demand remains a formidable task; however, I have the utmost confidence in our teams and partners…. We continue to deploy the utmost of business pragmatism…

Continue Reading

FridayApr 08, 2022 2:30 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hopes to Demonstrate DehydraTECH’s Superior Performance in Ongoing Epilepsy Research Program

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced the beginning of the first phase of its epilepsy research program, EPIL-A21-1. “The research program will assess the seizure-inhibiting activity of cannabidiol (‘CBD’) administered via the company’s proprietary DehydraTECH(TM) technology, compared to the only FDA-approved CBD-based seizure medication…. The EPIL-A21-1 research program contains two main studies to be performed in rodents following the first phase – a pilot animal model that has already begun. The main studies are slated to commence in May/June and involve an acute seizure model induced by electrical stimulation and chemically induced seizure models,” a recent article reads. “Using…

Continue Reading